Codex @codex  0

An anatomist investigates the structure and spatial organization of living bodies. Methods include dissection, imaging and histology; comparative work also asks how corresponding structures differ among organisms. Structural description becomes explanatory when it connects geometry to physiology and biological development.

Anatomy studies the structure and spatial organization of organisms. It connects the shapes of organs, the arrangement of tissues and the geometry of individual biological cells to the functions studied in physiology. Dissection, imaging and histology reveal complementary scales of organization.

A useful anatomical explanation makes relations explicit: a nerve passes through a canal, a tendon crosses a joint, or a thin epithelium separates two exchanging fluids. These relations explain why the same region can contain structures with different functions and why damage at one location can affect several systems.^[ref]

A bioactive glass is a glass designed to elicit a useful biological response at its interface, notably bonding with bone for some compositions and uses. It is a class of biomaterials, not a claim that every glass has the same response. Related glass-ceramics contain crystalline phases and should be distinguished from wholly glassy materials.

A motivating early experiment compared glass-ceramic solubility and interfacial hydroxyapatite crystallization with observations around implants in rat femurs. Larry L. Hench and colleagues examined histology and ultrastructure as well as laboratory interfacial changes. The question was how bonding developed at the material–bone interface, beyond the bulk material's mechanical strength.^[ref]

Contact with fluid can change the material's surface and release dissolved constituents. Geometry therefore matters alongside composition. For an original monodisperse spherical-powder model, radius $r$ and density $\rho$ give surface area per massAt stipulated $\rho =2500\mathrm{kg}{\mathrm{m}}^{-3}$ and $r=10\mu \mathrm{m}$, this is $120{\mathrm{m}}^2\mathrm{k}{\mathrm{g}}^{-1}$, or $0.12{\mathrm{m}}^2{\mathrm{g}}^{-1}$. Increasing radius to $100\mu \mathrm{m}$ reduces that area per mass tenfold. The example neglects pores and aggregation and is not a particular product's specification.

If initial release flux per unit area were equal in two such powders, their initial release rates per mass would differ by the same factor. Actual flux can change with solution composition and surface evolution; a biological response need not scale linearly with geometric area. Comparisons should therefore specify particle dimensions, exposed area, fluid conditions and time. Surface-layer formation, cytotoxicity, mechanical behavior and tissue bonding remain distinct observations rather than interchangeable proof of suitability.

In biomedical engineering, a biomaterial is a material selected or designed to interact with a biological system for a medical purpose. Its defining feature is this intended interaction, rather than whether it originated in an organism. A synthetic polymer, a metal or a ceramic can therefore be a biomaterial; natural collagen can also be processed for such a use. The biomedical meaning should be distinguished from the broader use of “bio” to mean material obtained from biomass.^[ref]

A biomaterial has both a material function and a biological environment. A load-bearing component must transmit forces without unacceptable deformation, but its surface also contacts fluid, proteins and biological cells. Biocompatibility consequently concerns an appropriate host response for a particular application; it is not a universal label that guarantees identical behavior at every site or for every exposure duration.^[ref]

An illuminating historical example is the 1971 work of L. L. Hench and colleagues on a bone-bonding glass-ceramic. They compared laboratory measurements of glass-ceramic solubility and interfacial hydroxyapatite crystallization with histology and ultrastructure observations around implants in rat femurs. The important question was how the material–bone interface developed, rather than merely whether the bulk ceramic was strong.^[ref]

To separate bulk behavior from an interface effect in a model experiment, one could compare specimens with identical dimensions and bulk Young's modulus but different surface treatments, while holding the cell culture conditions fixed. Measure both the mechanical response and cell adhesion, instead of substituting one for the other. Conversely, changing specimen thickness while retaining the same surface can change bending resistance without changing the nominal surface chemistry. These controlled comparisons show why evaluating a biomaterial requires specifying the material, its geometry, its interface and the biological setting together.

Clinicopathological correlation is the comparison of clinical observations with the findings in a pathological specimen to determine whether they form a coherent account of the same process. In dermatopathology, the clinical observations can include lesion location, appearance, size and change over time, while the specimen supplies microscopic tissue organization. These are complementary observations, not interchangeable measurements.

A skin biopsy is removed tissue sent for microscopic assessment and a written pathology report, as described by the American Academy of Dermatology.^[ref] Relating the report to the clinical question requires knowing what was sampled. A sample from the edge, the centre or an unrelated nearby site need not contain the same structures.

An original geometric example illustrates the issue. Suppose an observed lesion has a circular surface footprint $8\mathrm{mm}$ across and a circular $2\mathrm{mm}$-diameter sample lies wholly inside it. The sample covers the fractionof that projected area. This does not say that the remaining area has the same histology, or that one sixteenth of the three-dimensional lesion volume has been examined. It shows why a local finding cannot automatically stand for the complete visible lesion.

Correlation can also expose a mismatch: the tissue pattern may not account for the reported location or extent, or the specimen description may not match the documented sample. That discrepancy is information to investigate rather than a reason to force agreement. Conversely, a compatible clinical history does not prove every microscopic interpretation. Keeping the original observations and the resulting inference separate makes the reasoning testable.

In a study of the added value of clinical information, the same specimens could be interpreted with prespecified information withheld and then supplied, while controlling reading order and access to previous answers. The outcome would be a change in defined interpretations or reference agreement. Improvement cannot be assumed merely because more contextual information is available.

A cortical nephron is a nephron whose renal corpuscle lies relatively superficially in the renal cortex and whose Loop of Henle is usually shorter than that of a juxtamedullary nephron. The contrast concerns the position of the corpuscle and the depth of the loop. It does not mean that every part of a cortical nephron is confined to cortical tissue.^[ref]

A useful reconstruction starts at a glomerulus and follows the continuous tubule. A loop can enter the outer renal medulla and return to the cortex even though its corpuscle is superficial. A single transverse section through a tubule does not reveal either its complete path or the depth of its originating corpuscle. Thus anatomical tracing provides information beyond simply counting circular profiles in a histology image.

Both nephron classes perform glomerular filtration and tubular processing. Their different arrangements contribute differently to the medullary concentrating system, rather than dividing the kidney into a filtration-only class and a concentration-only class. Studies sampling visible surface tubules must also identify which nephrons are accessible before treating those samples as representative of all nephron types.^[ref]

Dermatopathology studies disease in sampled skin and its appendages through tissue structure, cellular appearance and the clinical context. It connects dermatology with histology: a visible lesion and a thin histological section of that lesion are different observations of the same biological process.

A skin biopsy provides a specimen rather than an automatic diagnosis. The interpretation depends on which part was sampled, how its structures are represented in the section and which biological question is being asked. Clinicopathological correlation relates the microscopic findings to the lesion's location, appearance and course. The American Academy of Dermatology describes the dermatopathologist's role in examining biopsy tissue and preparing a pathology report.^[ref]

Sampling geometry illustrates a limitation. In an original spherical-lesion model with radius $R$, a planar section a distance $z$ from the centre has apparent radiusFor $R=1\mathrm{mm}$, a central section shows diameter $2\mathrm{mm}$, whereas a section at $z=0.8\mathrm{mm}$ shows $1.2\mathrm{mm}$. A smaller profile does not establish that the original three-dimensional structure was smaller. This chosen geometry is explanatory, not a model for classifying a particular lesion.

Interpretation is itself testable. A primary observer study used 240 skin-biopsy cases assigned in sets for repeated interpretation at least eight months apart; 187 pathologists participated in its first phase. It evaluated diagnostic reproducibility and agreement with a consensus reference for melanocytic lesions.^[ref] Repeating classification separates within-observer consistency, between-observer variation and agreement with the defined reference.

These are distinct questions. Tissue processing and optical observation concern what evidence is available; classification concerns how that evidence is interpreted. A reproducible label need not answer every clinical question, and a consensus reference is an explicitly constructed comparator rather than direct access to every aspect of biological truth.

Historical soft, brain-like malignant growth. The gross appearance does not specify one modern diagnosis in histology.

Histology studies the microscopic organization of tissues. Thin sections, imaging and histological staining reveal how cells and extracellular matrix form a working structure. A two-dimensional section samples a three-dimensional arrangement, so section orientation and preparation influence interpretation.

Larry L. Hench (1938–2015) was a materials scientist known for developing bioactive glass: a biomaterial designed to form a bond with living bone. The National Academy of Engineering memorial records his name, dates and contribution to bioactive glasses and glass corrosion.^[ref]

His own account explains the key experimental observation: early glass specimens implanted in rat femurs became bonded to bone. The scientific question was how the solid’s composition and its reactions with body fluid could create that interface. The proposed mechanism involved dissolution and formation of a mineral-rich surface layer, followed by biological attachment.^[ref] The earlier joint paper compared solubility and interfacial hydroxyapatite crystallization studies with implant histology and ultrastructure.^[ref]

This work changed the design question from simply finding a strong solid to understanding a solid–tissue system. A bond at the interface and sufficient bulk strength are distinct properties: a strong implant can still detach at its surface, while a bonded but weak material can fail internally. Testing where a loaded specimen separates helps distinguish these possibilities. That distinction connects Hench’s experimental approach to biocompatibility, biomechanics and tissue engineering.

Laser capture microdissection selects small regions or cell populations from a tissue section under microscope guidance, using a laser-mediated collection step. Its purpose is to connect visible histology with molecular measurements from a chosen location. Selection is not the same as preparing the original thin section, and a visible target boundary does not by itself guarantee pure or complete recovery.

The 1996 demonstration by Michael R. Emmert-Buck and colleagues placed a transparent ethylene-vinyl acetate thermoplastic film against a section on a glass slide. A carbon dioxide laser pulse activated the film locally above the desired cells. Focal adhesion enabled transfer of the selected tissue. The reported mechanism was capture by the activated film, rather than simply assuming that the target cells were vaporized. Other laser-assisted cutting arrangements need not use that same transfer mechanism.^[ref]

The original paper demonstrated amplification of recovered DNA and RNA and recovery of enzyme activity. Those tests connect the collection apparatus with useful downstream assays; they do not prove that every molecular species survives equally or that every captured region consists of one cell type.^[ref]

An original selection model separates purity from yield. Suppose a section contains 100 target cells and 900 background cells. If capture retains $80\%$ of targets but $1\%$ of background, the recovered group has 80 targets and 9 background cells. Target purity is $80/89\simeq 89.9\%$, while target recovery is $80/100=80\%$. Enrichment can therefore be strong even when some desired cells are lost. In general, with initial target fraction $p$ and capture probabilities $q_T,q_B$,provided the denominator is positive. This model assumes independent per-cell accounting, not that an actual laser footprint captures each cell independently.

A measurement record can preserve specimen images before and after collection, the intended boundaries and an assay-specific blank. Images can show spatial removal; a blank can reveal film or collection-background contributions. Target purity versus cell-state change in microdissection then explains why a molecular signal increase after collection may reflect altered population composition rather than altered expression within each target cell.

Preparation time is a separate experimental variable. The RNA-preservation study by Mathieu Clément-Ziza and colleagues tested dry-environment and ethanol-based methods while measuring RNA integrity over the collection period. Keeping a recognizable histological staining pattern and recovering intact RNA are related requirements, but they are distinct measurements.^[ref]

Luteinization is the differentiation and reorganization of follicular cells into the steroid-secreting cells of the corpus luteum. Granulosa cells and theca cells change their endocrine activity, with increased capacity for progesterone production. In the normal ovarian cycle, the luteinizing hormone surge coordinates this process with ovulation. Release of the oocyte and transformation of the remaining follicular tissue are nevertheless distinct events.^[ref]

A functional experiment examines what the differentiated cells actually make. In a 1991 study, human luteinized granulosa cells were cultured for 48 hours with or without human chorionic gonadotropin or follicle-stimulating hormone. The investigators measured several steroids and assayed aromatase activity separately. Progesterone production was prominent and responsive to stimulation, demonstrating endocrine activity in the luteinized preparation.^[ref]

This motivates a useful distinction between cell state and one of its outputs. Increased progesterone is evidence of altered steroid production, but one concentration measurement does not by itself prove that a whole follicle has ruptured, that an oocyte was released, or that every structural step of luteinization occurred. Comparing histology with biochemical measurements makes the interpretation more precise.

Microdissection is the isolation of small selected structures or regions from a specimen under microscope guidance. It links the spatial organization studied in histology with assays of a chosen cell population. Unlike a microtome, which prepares thin sections, microdissection selects a particular region or constituent from material being examined.

Selection can be performed with fine mechanical tools or with instrument-assisted methods. A concrete landmark is the 1996 primary demonstration of laser capture microdissection by Michael R. Emmert-Buck and colleagues. Their apparatus placed a transparent ethylene-vinyl acetate thermoplastic film on a tissue section and used a carbon-dioxide laser pulse to activate the film over chosen cells. Adhesion allowed those cells to be collected. The paper demonstrated subsequent DNA/RNA amplification and enzyme recovery.^[ref] This describes that published apparatus; capture and cutting methods need not use the same laser or transfer mechanism.

Target purity versus cell-state change in microdissection explains why spatial selection matters. In an original simple assay model, suppose target and background cells contribute calibrated signals $a$ and $b$ per cell. For target-cell fraction $p$, the per-cell mean of an equally weighted sample is $y=pa+(1-p)b$. With stipulated $a=100$, $b=0$, changing purity from 10% to 50% changes the mean from 10 to 50 units without any change in the target cells' own signal. An apparent increase can reflect enrichment rather than altered gene expression.

Conversely, a selected region need not be chemically pure. The footprint can include neighbouring cells, and tissue preparation or transfer can affect recovery of DNA, RNA and proteins. Normalization per cell, per total extracted RNA and per tissue area therefore asks different quantitative questions.

A useful experiment records the specimen image before and after selection, the chosen boundaries, collection yield and relevant background controls. Microdissection improves the connection between location and molecular measurement; it does not by itself prove cell identity, eliminate all contamination or establish that a recovered molecular difference is intrinsic to one cell type.

A suitable published comparison is J. B. Junor's 1858 report of cardiac rupture with a soft, fatty ventricular wall and blood in the pericardium. The comparison comes from the published clinical record.

The patient was a woman of about seventy with repeated vomiting and an initially weak pulse. She deteriorated after a severe episode of vomiting, her radial pulse becoming almost imperceptible, and died a few hours later. At examination after death, a large gallstone was found impacted in the ileum. The pericardium contained much blood. The small, atrophied heart had an extremely soft and fatty right cardiac ventricle; when it was raised, blood emerged through several small fissures, and its tissue broke under very gentle handling. ^[ref]

The comparison is anatomical and pathological: a fragile ventricular wall, escape of blood and death. There are also important differences. Morgagni's tear is in the left cardiac ventricle; J. B. Junor's reported fissures concern the right cardiac ventricle and were described during handling of a very friable heart. The latter account includes intestinal obstruction and does not reproduce Morgagni's sternal and arm pain. It supports the possibility of severe muscular degeneration in a ruptured heart, without establishing that the two patients had identical disease or that every observed fissure opened before death.

Probable muscular condition in an 1864 answer. The fibres around the tear were probably structurally weakened and softened; fatty degeneration of the heart is a strong historical pathological suggestion. This means alteration within damaged muscular fibres, rather than merely an abundance of adipose tissue outside them. In Richard Quain's account, reproduced before the examination, microscopic fatty change involved loss of the normal transverse markings and refractile fatty particles within the fibre sheath. Extensive change could accompany a pale, mottled, flabby myocardium. Those are findings one would look for, not observations supplied by the Oxford passage. ^[ref]

An appropriate investigation would compare thin preparations from the tear's margin with apparently unaffected myocardium under a microscope, looking at the cross-striation, continuity of the muscular structure and position of the fatty particles. Fat lying between bundles is different from particles lying within damaged fibres. The gross appearance, the microscopic preparation and the sampling site must be reported separately. The word “erosion” does not by itself supply these microscopic findings. ^[ref]

Modern interpretation and its limit. Rupture of a left ventricular free wall can follow myocardial infarction, where a zone of damaged myocardium becomes friable. That is a plausible modern differential for the combination of chest and arm pain, weak pulse and a tear, but the historical record does not supply coronary anatomy or histology sufficient to prove it. A sudden collection of blood in the pericardium, or haemopericardium, can impair cardiac filling and cause cardiac tamponade. This provides a mechanism compatible with the abrupt pallor and collapse; pericardial pressure was not measured in the reported case. Present-day assessment could use urgent echocardiography; that technology belongs to the later comparison. ^[ref]

The defensible conclusion is a ruptured, locally weakened myocardium, with fatty degeneration of the heart a probable nineteenth-century interpretation and infarct-related damage a modern possibility requiring additional evidence.

The classical contrast is between ulceration centred on intestinal lymphoid tissue in enteric fever and granulomatous, often circumferential ulceration in intestinal tuberculosis. The historical expression continued fever covered more than one illness. The characteristic bowel lesions meant here point especially to typhoid fever; they should not be attributed indiscriminately to typhus or every prolonged fever.

In typhoid fever, Peyer's patches and solitary lymphoid follicles, particularly in the terminal ileum, enlarge and become infiltrated. Their breakdown and necrosis lead to sloughing and ulceration. The larger ulcers characteristically follow the long axis of the intestine, reflecting the shape of the affected aggregated lymphoid patch on the side opposite the mesentery. Depending on their stage, one may see swollen patches, necrotic sloughs, open ulcers or healing surfaces. Depth varies; erosion into a blood vessel can cause haemorrhage, while full-thickness destruction can cause intestinal perforation and peritonitis.

Microscopically, the important cellular component includes swollen macrophages with ingested organisms and cellular debris; this is not simply a dense collection of neutrophils forming an ordinary abscess. The surrounding mucosal architecture may become severely disturbed. These current cellular descriptions refine the gross lesion recognized before the causative organism was identified.^[ref][ref]

In historical phthisis, bowel disease frequently meant intestinal tuberculosis associated with pulmonary tuberculosis. Lesions commonly involve the terminal ileum and ileocaecal region, although other sites occur. Nodules in mucosal or submucosal lymphoid tissue undergo caseous necrosis, coalesce and break through the mucosa. The ulcerated surface tends to spread transversely and may encircle the bowel. The edges can be irregular and undermined, with additional tuberculous granulomas in the wall, serosal surface or draining lymph nodes. Progressive fibrosis may narrow the lumen and produce a stricture; thickened masses as well as ulcers can occur.^[ref]

A section from a tuberculous ulcer may show central caseous necrosis bordered by epithelioid macrophages, giant cells and lymphocytes. A section from an enteric-fever ulcer instead emphasizes destruction of lymphoid patches with macrophage-rich infiltration. A practical anatomical examination records site, orientation, depth, edges, intervening mucosa, serosal nodules and draining lymph nodes, rather than judging one detached fragment in isolation.

Longitudinal lymphoid-patch ulcers favour the classical enteric-fever pattern; transverse, caseating and often stenosing lesions favour intestinal tuberculosis. These are useful patterns rather than absolute rules. Modern microbiological culture, organism-specific molecular tests and appropriately sampled histology can establish the cause when gross appearances overlap.

The historical arguments rested on similarities of cellular origin, degeneration and tissue reaction; they did not establish that tuberculosis, cancer and inflammation were one disease. The question asks for the arguments advanced, so their evidential force must be separated from their historical importance.

First, microscopy revealed biological cells and cell nuclei in all three lesions. An older theory made morbid cells arise in an exuded formative fluid; cellular pathology sought their origins in pre-existing tissue. William Turner's 1863 lecture explicitly compared the origins of corpuscles in pus, cancer and tubercle, but acknowledged their later divergence and unexplained specific characters. A common cellular origin could therefore suggest a relationship without establishing identity.^[ref]

Second, microscopic particles thought specific to tubercle could resemble shrunken biological cells, free cell nuclei and degenerated products in malignant or inflammatory lesions. Yellow caseous material was also not uniquely tuberculous. The 1860 year-book records the argument that so-called yellow tubercle could be the outcome of degeneration rather than a specific material already present in blood. This weakened the claim that the appearance of the end product alone established a separate deposited substance.^[ref]

Third, inflamed, injured or ulcerated regions can show exuberant growth, increased vascularity and infiltrating leukocytes. A tumour can itself ulcerate and become inflamed; a tuberculous focus can provoke surrounding inflammation and scarring. Such anatomical continuity offered an argument for a connection, but several explanations fit it: the inflammatory reaction might cause some changes, respond to the primary lesion, or merely coexist with it. A section containing all these features does not by itself identify their temporal order.

The correct assessment distinguishes shared cellular responses from shared cause. Modern tuberculosis involves an infectious organism and a host response that can include granulomas and caseous necrosis. Modern cancer involves malignant cellular growth with disease-specific molecular and tissue features. Inflammation is a response to diverse injuries and infections, not automatically an incipient cancer or a tubercle. Modern inflammation also commonly recruits leukocytes from circulating blood, so the historical proposal of universal local connective-tissue origin was itself incomplete. Histology must retain viable margins and tissue architecture rather than comparing only amorphous debris.

There is nevertheless a real modern connection between persistent inflammation and some cancers: chronic inflammatory processes can damage DNA and alter the environment in which biological cells proliferate. That supports particular causal pathways, not universal identity, and it does not mean that an ordinary inflammatory lesion inevitably becomes malignant.^[ref] The strongest historical insight was a common cellular basis of pathology; the overreach was to infer a common disease from a common reaction or a similar degenerated product.

Examine the whole body before disturbing the wound, recording its situation, dimensions, margins and relation to damaged blood vessels. Then expose the wound track by careful dissection. An injury received while the blood circulation was active may show substantial hemorrhage, blood infiltrating the surrounding tissue, and adherent blood clots. Infiltration is more informative than loose blood merely lying on the surface: serial cuts can show whether blood has penetrated the tissue rather than simply coated it.

The interval of survival changes what can reasonably be expected. If the person survived long enough, surrounding inflammation, cellular reaction, formation of granulation tissue, or an established scar is evidence of a process that began during life. Such findings can make the conclusion much stronger than the appearance of a fresh cut. They do not furnish a universal clock: wound healing varies with site, severity, health and environment.

A post-mortem cut will often have relatively pale margins and little infiltration, although it can gape because skin and other tissues are elastic. Blood may still escape from a recently dead body, particularly from dependent or congested parts, and coagulation can occur around the time of death. Livor mortis can resemble bruising, while drying and putrefaction alter colour and consistency. A body moved, compressed or subjected to attempts at resuscitation presents further opportunities for artefact. Therefore neither “it bled” nor “the edges retracted” establishes that the wound was inflicted during life.

For modern corroboration, sample the margin, underlying tissue and an uninjured comparison site for histology, interpreting inflammation and other markers in the context of the whole examination. A primary study of decomposed forensic cases illustrates the use of immunohistochemistry while explicitly warning that extravasated red blood cells alone do not reliably establish wound vitality.^[ref]

Consequently, a rapidly fatal wound may be impossible to distinguish confidently from one inflicted immediately after death by gross aspect alone. Absence of developed inflammation is expected when survival was extremely brief; it is not proof of post-mortem injury. The answer should express the degree of support, rather than force an unwarranted yes-or-no conclusion.

There is no single constant anatomical lesion of epilepsy. A sound autopsy answer separates an underlying brain lesion, changes associated with longstanding epilepsy, and the consequences of the final seizure or death.

The potentially causal group includes healed traumatic scars, old cerebral infarctions or intracranial haemorrhages, developmental abnormalities of the cerebral cortex, brain tumours, and inflammatory or infectious destruction of brain tissue. Such abnormalities can leave an enduring network capable of generating recurrent seizures. Their importance depends on location and the lifetime history; an incidental abnormality is not automatically the cause. A modern acute symptomatic seizure during a transient metabolic disturbance should also not automatically be called epilepsy.^[ref]

In longstanding cases one may find atrophy or scarring of particular brain regions. Hippocampal sclerosis is an important modern example: loss of neurons with gliosis in the hippocampus, associated especially with temporal-lobe epilepsy. Association does not settle whether a particular lesion preceded the first seizure, resulted from repeated seizures, or shares another cause with them. Conversely, genetically determined disturbances of neuronal excitability can produce recurrent seizures without a grossly visible destructive lesion.^[ref]

For the historical question, vascular redness or congestion and alterations around the medulla oblongata deserve mention as contemporary observations rather than established universal causes. A January 1864 report describes microscopic examination of fourteen longstanding cases, including dilated blood vessels and altered nervous material in that region. Its proposed localization of epilepsy to the medulla oblongata is a historical theory; modern epilepsy is not defined by that site or by those vascular appearances.^[ref]

The terminal group includes cerebral oedema, hypoxic-ischaemic brain injury, and pulmonary oedema or aspiration in some deaths. Congestion is nonspecific and may be terminal; injuries can result from a fall during a seizure. None of these alone establishes that epilepsy was the original cause. A modern autopsy study of sudden deaths in people with epilepsy found both structural abnormalities and nonspecific changes; exclusion of another anatomical or toxicological cause remains central to classifying sudden unexpected death in epilepsy.^[ref]

The appropriate investigation is therefore inspection followed by systematic histology, especially of the cerebral cortex and hippocampus on both sides, interpreted alongside the recorded seizure history and examination of other organs. A normal-looking brain does not exclude epilepsy, and a congested one does not prove it.

Historical “amyloid disease” denotes the waxy or lardaceous visceral change, especially in the spleen, liver and kidneys; modern amyloidosis denotes deposition of misfolded protein fibrils. The old descriptive appearance and the modern chemical explanation must be kept distinct.

In nineteenth-century usage the affected organs could be enlarged, firm and unusually translucent or wax-like on section. The name amyloid means starch-like. The historical chemical argument relied on colour reactions with iodine and sulfuric acid, suggesting affinity with starch or cellulose. Such a reaction was a clue to recognition, not a modern identification of the deposited substance. Rudolf Virchow's 1856 account explicitly discusses the waxy change of the spleen, liver and kidneys, and its occurrence with longstanding destructive disease.^[ref]

The three principal visceral examples can be described more precisely:

The distribution is not confined to those three organs. Amyloidosis can also affect the gastrointestinal tract, heart, blood vessels and other sites; the pattern depends on the precursor protein. Modern examples include AA amyloidosis associated with sustained inflammation, AL amyloidosis involving immunoglobulin light chains, and transthyretin amyloidosis. This classification is a present-day explanation, not a list of molecular diagnoses asserted for unnamed 1867 patients.^[ref]

Modern confirmation uses histology with Congo red and examination with a polarizing microscope, followed by identification of the deposited protein, for example with mass spectrometry. The characteristic birefringence supports identification of amyloid; typing distinguishes biologically different diseases. These are later laboratory methods, not apparatus available to the candidate in 1867.^[ref]

Thus an adequate historical list starts with spleen, liver and kidneys, while the modern explanation is extracellular protein deposition rather than conversion of an organ into starch.

The chief physiological routes are abrupt failure of blood circulation, failure of pulmonary ventilation or gas exchange, or catastrophic failure of the central control of those functions. Historical clinical accounts used labels such as syncope, asphyxia and medical coma in explaining deaths; these terms describe broad physiological failures rather than identifying the underlying diseases.^[ref] A brief faint or ordinary medical coma is not itself necessarily fatal.

In primary circulatory failure, effective delivery of blood to the brain stops. Modern examples include ventricular fibrillation, pulseless ventricular tachycardia, severe bradyarrhythmia and asystole. They may arise in coronary artery disease, after myocardial infarction, in cardiomyopathy, or from inherited cardiac ion channel disorders. An electrical cause may leave little distinctive gross evidence at autopsy. These modern mechanisms refine the broad historical description of cardiac syncope.^[ref]

Mechanical interruption of blood circulation gives another group: massive haemorrhage, rupture of an aortic aneurysm, cardiac tamponade, and large pulmonary embolism. The immediate deficit differs in each. Haemorrhage removes circulating volume; cardiac tamponade prevents adequate filling; pulmonary embolism obstructs flow through the pulmonary circulation. All can end with critically low cardiac output even if some electrical activity persists.^[ref]

Respiratory failure includes obstruction of the airway by a foreign body, laryngeal oedema or aspiration; drowning; and depression of breathing by drugs or major brainstem injury. Oxygen delivery then fails and secondary cardiac arrest follows. Carbon monoxide poisoning and cyanide poisoning illustrate related failure of oxygen transport or use: not every hypoxic death is caused by physical obstruction of an airway.^{[ref][ref][ref]}

A major intracranial haemorrhage or rapidly developing brain herniation can destroy or compress the pathways maintaining consciousness and breathing. A severe disturbance of electrolytes, especially potassium, may instead act directly on the heart's electrical function. A fatal seizure can involve respiratory and circulatory mechanisms; sudden unexpected death in epilepsy remains a diagnosis requiring exclusion of other causes, not merely recognition of a history of epilepsy.^[ref]

The practical distinction is between mode, immediate mechanism and underlying cause. For example, rupture of an aneurysm can cause haemorrhage, then circulatory failure, then irreversible hypoxic-ischaemic brain injury. A complete explanation identifies that chain. Inspection, histology, examination of the airway and heart, and appropriately interpreted toxicology may establish it; an unexplained sudden death cannot be assigned a precise cause from its suddenness alone.